Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22103066 | 0.65 | ANPEP (0.60) | ANPEPLAP3 | |
| SCHEMBL21190520 | 0.65 | ANPEP (0.60) | ANPEPLAP3 | |
| SCHEMBL20755854 | 0.61 | ANPEP (0.55) | ANPEPLAP3 | |
| SCHEMBL23266362 | 0.61 | ANPEP (0.55) | ANPEPLAP3 | |
| SCHEMBL10592383 | 0.61 | ANPEP (1.00) | ANPEPLAP3 | |
| SCHEMBL23969659 | 0.61 | ANPEP (0.55) | ANPEPLAP3 | |
| SCHEMBL22005279 | 0.61 | ANPEP (0.55) | ANPEPLAP3 | |
| SCHEMBL24526101 | 0.61 | ANPEP (0.55) | ANPEPLAP3 | |
| SCHEMBL20633200 | 0.61 | ANPEP (0.55) | ANPEPLAP3 | |
| SCHEMBL21019857 | 0.61 | ANPEP (0.55) | ANPEPLAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070275968-A1 | Substituted Biphenyl Derivative | SANKYO COMPANY, LIMITED (JP) | 2007-11-29 | — | — | US | disclosed |
| EP-1798229-A1 | SUBSTITUTED BIPHENYL DERIVATIVE | Sankyo Company, Limited (JP) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070275968-A1 | Substituted Biphenyl Derivative | COL2A1, COL1A1, FGFR3 | ANPEP 1436/4885LAP3 208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.